Although we have shown that human fetal intestinal epithelial cells provide an easy system to test the cytotoxicity of AChE inhibitors, further efficacy studies need to be conducted in mouse and monkey models of Alzheimer’s disease before any new compound can be studied in human clinical trials. This evidence concerns the gene ACHE and early-onset autosomal dominant Alzheimer disease.